CpG 1018 | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website
  • Membership Drive Update: In the first 48 hours we've hit almost 20% of our goal. An encouraging start to be sure, but we can't stop now. We need to pull enough subscription revenue forward to counter severe cash flow deficits resulting from a dramatic slow-down in ad spend thanks to the global pandemic which shows no signs of letting up in the near-term. We're doing everything in our power to keep our heads above some very choppy water, but we can't do it alone. We need your help. So if you've ever thought about giving our premium service a try, there's no better time to do it than right now by taking advantage of one of our discounted multi-year plans. Thanks in advance for your continued loyalty & support! 

  • Limited Premium Membership Offer
    Choose a Plan, Save Money & Help Us Survive the Pandemic

    Lifetime @ $399 (only 24 left) 5-yrs @ $199 (only 30 left) 2-yrs @ $99 (only 27 left)

DVAX   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1757 of 1779  at  8/7/2020 4:39:25 PM  by


 In response to msg 1750 by  fairvalueforyou
view thread

Re: CpG 1018

I have little doubt that better adjuvants can be made / already exist, but the FDA beat the daylights out of DVAX for years and years because Heplisav included a novel adjuvant.
So, I would imagine that CpG 1018, as an FDA approved product, is worth more Right Now than a technically superior product that is still undergoing clinical assessment?  Especially true for time-critical C-19 vaccine development. 

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 58
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
1758 Re: CpG 1018 fairvalueforyou 1 8/7/2020 6:18:25 PM
1759 Re: CpG 1018 liuyiiv 0 8/7/2020 7:15:18 PM

Financial Market Data provided by